0001517941-17-000003.txt : 20171003
0001517941-17-000003.hdr.sgml : 20171003
20171003093606
ACCESSION NUMBER: 0001517941-17-000003
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20171003
DATE AS OF CHANGE: 20171003
EFFECTIVENESS DATE: 20171003
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Carmell Therapeutics Corp
CENTRAL INDEX KEY: 0001517941
IRS NUMBER: 263671988
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-295847
FILM NUMBER: 171116286
BUSINESS ADDRESS:
STREET 1: 10 SOUTH TOWER
STREET 2: 320 E. NORTH AVENUE
CITY: PITTSBURGH
STATE: PA
ZIP: 15212
BUSINESS PHONE: (412) 508-6519
MAIL ADDRESS:
STREET 1: 10 SOUTH TOWER
STREET 2: 320 E. NORTH AVENUE
CITY: PITTSBURGH
STATE: PA
ZIP: 15212
D
1
primary_doc.xml
X0708
D
LIVE
0001517941
Carmell Therapeutics Corp
2403 Sidney Street
Suite 300
PITTSBURGH
PA
PENNSYLVANIA
15203
215-688-6196
DELAWARE
CarMell, LLC
None
Corporation
true
Randolph
Hubbell
c/o Carmell Therapeutics Corporation
2403 Sidney Street, Suite 300
Pittsburgh
PA
PENNSYLVANIA
15203
Executive Officer
Director
James
Hart
c/o Carmell Therapeutics Corporation
2403 Sidney Street, Suite 300
Pittsburgh
PA
PENNSYLVANIA
15203
Executive Officer
Donna
Godward
c/o Carmell Therapeutics Corporation
2403 Sidney Street, Suite 300
Pittsburgh
PA
PENNSYLVANIA
15203
Executive Officer
Richard
Upton
c/o Carmell Therapeutics Corporation
2403 Sidney Street, Suite 300
Pittsburgh
PA
PENNSYLVANIA
15203
Director
James
F.
Jordan
c/o Carmell Therapeutics Corporation
2403 Sidney Street, Suite 300
Pittsburgh
PA
PENNSYLVANIA
15203
Director
David
W.
Anderson
c/o Carmell Therapeutics Corporation
2403 Sidney Street, Suite 300
Pittsburgh
PA
PENNSYLVANIA
15203
Director
Stephanie
Kladakis
c/o Carmell Therapeutics Corporation
2403 Sidney Street, Suite 300
Pittsburgh
PA
PENNSYLVANIA
15203
Executive Officer
Biotechnology
Decline to Disclose
- 06b
false
2017-09-28
false
true
false
25000
1500000
398235
1101765
false
4
0
0
0
false
Carmell Therapeutics Corp
Randolph W. Hubbell
Randolph W. Hubbell
Chief Executive Officer and President
2017-10-03